Sarkis Meterissian - Net Worth and Insider Trading
Sarkis Meterissian Net Worth
The estimated net worth of Sarkis Meterissian is at least $14,160 dollars as of 2024-11-13. Sarkis Meterissian is the Director of Defence Therapeutics Inc and owns about 24,000 shares of Defence Therapeutics Inc (XCNQ:DTC) stock worth over $14,160. Details can be seen in Sarkis Meterissian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sarkis Meterissian has not made any transactions after 2023-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sarkis Meterissian
Sarkis Meterissian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sarkis Meterissian owns 1 companies in total, including Defence Therapeutics Inc (XCNQ:DTC) .
Click here to see the complete history of Sarkis Meterissian’s form 4 insider trades.
Insider Ownership Summary of Sarkis Meterissian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:DTC | Defence Therapeutics Inc | 2023-12-08 | Director |
Sarkis Meterissian Latest Holdings Summary
Sarkis Meterissian currently owns a total of 1 stock. Sarkis Meterissian owns 24,000 shares of Defence Therapeutics Inc (XCNQ:DTC) as of December 8, 2023, with a value of $14,160.
Latest Holdings of Sarkis Meterissian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:DTC | Defence Therapeutics Inc | 2023-12-08 | 24,000 | 0.59 | 14,160 |
Holding Weightings of Sarkis Meterissian
Sarkis Meterissian Form 4 Trading Tracker
According to the SEC Form 4 filings, Sarkis Meterissian has made a total of 2 transactions in Defence Therapeutics Inc (XCNQ:DTC) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Defence Therapeutics Inc is the sale of 6,000 shares on December 8, 2023, which brought Sarkis Meterissian around $16,500.
Insider Trading History of Sarkis Meterissian
- 1
Sarkis Meterissian Trading Performance
Sarkis Meterissian Ownership Network
Ownership Network List of Sarkis Meterissian
Ownership Network Relation of Sarkis Meterissian
Sarkis Meterissian Owned Company Details
What does Defence Therapeutics Inc do?
Who are the key executives at Defence Therapeutics Inc?
Sarkis Meterissian is the Director of Defence Therapeutics Inc. Other key executives at Defence Therapeutics Inc include and Director & Senior Officer Patrick Joseph Meagher .
Defence Therapeutics Inc (XCNQ:DTC) Insider Trades Summary
Over the past 18 months, Sarkis Meterissian made 2 insider transaction in Defence Therapeutics Inc (XCNQ:DTC) with a net sale of 8,000. Other recent insider transactions involving Defence Therapeutics Inc (XCNQ:DTC) include a net purchase of 2,500 shares made by Daniel Kwin Grauer , a net purchase of 2,500 shares made by Patrick Joseph Meagher ,
In summary, during the past 3 months, insiders sold 0 shares of Defence Therapeutics Inc (XCNQ:DTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,000 shares of Defence Therapeutics Inc (XCNQ:DTC) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 3,000 shares.
Defence Therapeutics Inc (XCNQ:DTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Defence Therapeutics Inc Insider Transactions
Sarkis Meterissian Mailing Address
Above is the net worth, insider trading, and ownership report for Sarkis Meterissian. Currently GuruFocus does not have mailing address information for Sarkis Meterissian.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
